Rolf Herzog

1.4k total citations · 1 hit paper
26 papers, 766 citations indexed

About

Rolf Herzog is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Rolf Herzog has authored 26 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Physiology. Recurrent topics in Rolf Herzog's work include Phosphodiesterase function and regulation (9 papers), Receptor Mechanisms and Signaling (4 papers) and Asthma and respiratory diseases (4 papers). Rolf Herzog is often cited by papers focused on Phosphodiesterase function and regulation (9 papers), Receptor Mechanisms and Signaling (4 papers) and Asthma and respiratory diseases (4 papers). Rolf Herzog collaborates with scholars based in Germany, United States and Switzerland. Rolf Herzog's co-authors include Lila Abu‐Lughod, Karl Zech, Róbert Hermann, Gëzim Lahu, Oliver von Richter, Nassr Nassr, Nigel McCracken, Thomas D. Bethke, Martin W. Elmlinger and Dieter Hauschke and has published in prestigious journals such as Clinical Pharmacokinetics, British Journal of Clinical Pharmacology and Journal of Chromatography B.

In The Last Decade

Rolf Herzog

26 papers receiving 655 citations

Hit Papers

Veiled Sentiments: Honor and Poetry in a Bedouin Society 1987 2026 2000 2013 1987 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Veiled Sentiments: Honor and Poetry in a Bedouin Society
    1987 447 citations Rolf Herzog, Lila Abu‐Lughod The International Journal of African Historical Studies profile →

Peers

Rolf Herzog
Paul A. Kramer United States
James Dow United States
Elisabeth Hsü United Kingdom
J. Vernon Jensen United States
David R. Rudy United States
Daniel Aaron United States
Jane Holgate United Kingdom
Carolyn Hamilton South Africa
Timothy Lynch Australia
Joseph M. Bryant United States
Paul A. Kramer United States
Rolf Herzog
Citations per year, relative to Rolf Herzog Rolf Herzog (= 1×) peers Paul A. Kramer

Countries citing papers authored by Rolf Herzog

Since Specialization
Citations

This map shows the geographic impact of Rolf Herzog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Herzog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Herzog more than expected).

Fields of papers citing papers by Rolf Herzog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Herzog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Herzog. The network helps show where Rolf Herzog may publish in the future.

Co-authorship network of co-authors of Rolf Herzog

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Herzog. A scholar is included among the top collaborators of Rolf Herzog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Herzog. Rolf Herzog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nave, R., Atef Halabi, Rolf Herzog, et al.. (2012). Pharmacokinetics of teduglutide in subjects with renal impairment. European Journal of Clinical Pharmacology. 69(5). 1149–1155. 16 indexed citations
3.
Ratner, Paul H., Mark A. Wingertzahn, Rolf Herzog, et al.. (2011). An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis. Pulmonary Pharmacology & Therapeutics. 24(4). 426–433. 4 indexed citations
4.
Lahu, Gëzim, Nassr Nassr, Rolf Herzog, et al.. (2010). Effect of Steady-State Enoxacin on Single-Dose Pharmacokinetics of Roflumilast and Roflumilast N-Oxide. The Journal of Clinical Pharmacology. 51(4). 586–593. 18 indexed citations
5.
Nassr, Nassr, Rolf Herzog, Oliver von Richter, et al.. (2009). Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N‐oxide in healthy subjects. British Journal of Clinical Pharmacology. 68(4). 580–587. 34 indexed citations
6.
Herzog, Rolf, et al.. (2009). Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide. International Journal of Clinical Pharmacology and Therapeutics. 47(4). 236–245. 24 indexed citations
7.
8.
Neville, Kathleen, Stanley J. Szefler, Gëzim Lahu, et al.. (2008). Single‐Dose Pharmacokinetics of Roflumilast in Children and Adolescents. The Journal of Clinical Pharmacology. 48(8). 978–985. 10 indexed citations
9.
Lahu, Gëzim, Oliver von Richter, Róbert Hermann, et al.. (2008). Effect of Single and Repeated Doses of Ketoconazole on the Pharmacokinetics of Roflumilast and Roflumilast N‐Oxide. The Journal of Clinical Pharmacology. 48(11). 1339–1349. 30 indexed citations
10.
Richter, Oliver von, et al.. (2007). Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and??Roflumilast??N-Oxide. Clinical Pharmacokinetics. 46(7). 613–622. 29 indexed citations
11.
Hermann, Róbert, Nassr Nassr, Gëzim Lahu, et al.. (2007). Steady-State Pharmacokinetics of Roflumilast and Roflumilast N-Oxide in Patients with Mild and Moderate Liver Cirrhosis. Clinical Pharmacokinetics. 46(5). 403–416. 32 indexed citations
12.
Hauns, Bernhard, Róbert Hermann, Rolf Herzog, et al.. (2006). Investigation of a Potential Food Effect on the Pharmacokinetics of Roflumilast, an Oral, Once‐Daily Phosphodiesterase 4 Inhibitor, in Healthy Subjects. The Journal of Clinical Pharmacology. 46(10). 1146–1153. 37 indexed citations
13.
Herzog, Rolf. (1998). PostgreSQL--The Linux of Databases. Linux journal. 1998(46). 1. 5 indexed citations
14.
Herzog, Rolf, et al.. (1995). A pilot study on the determination of the relative bioavailability of levo-thyroxine.. PubMed. 17(5). 333–43. 3 indexed citations
15.
Fuder, H., et al.. (1994). Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.. PubMed. 16(9). 651–60. 4 indexed citations
16.
Herzog, Rolf & J Leuschner. (1994). Reproductive toxicity studies of benzalazine in rats and rabbits.. PubMed. 44(12). 1368–70. 2 indexed citations
17.
Herzog, Rolf & Lila Abu‐Lughod. (1987). Veiled Sentiments: Honor and Poetry in a Bedouin Society. The International Journal of African Historical Studies. 20(4). 758–758. 447 indexed citations breakdown →
18.
Morel, Ademir F., et al.. (1984). Ein neues Peptidalkaloid aus Discaria febrifuga Mart / A New Peptide Alkaloid from Discaria febrifuga Mart. Zeitschrift für Naturforschung B. 39(12). 1825–1827. 12 indexed citations
19.
Herzog, Rolf. (1963). Seßhaftwerden von Nomaden. VS Verlag für Sozialwissenschaften eBooks. 3 indexed citations
20.
Herzog, Rolf. (1957). Die Nubier. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul A. Kramer Breakdown of academic impact, for papers by James Dow Breakdown of academic impact, for papers by Elisabeth Hsü Breakdown of academic impact, for papers by J. Vernon Jensen Breakdown of academic impact, for papers by David R. Rudy Breakdown of academic impact, for papers by Daniel Aaron Breakdown of academic impact, for papers by Jane Holgate Breakdown of academic impact, for papers by Carolyn Hamilton Breakdown of academic impact, for papers by Timothy Lynch Breakdown of academic impact, for papers by Joseph M. Bryant
Rankless by CCL
2026